The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20082286
The Journal of Experimental Medicine, Vol. 206, No. 11, 2407-2416
The Rockefeller University Press, 0022-1007 $30.00
© Das et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4047K)
Right arrow PDF+supp data (6875K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Das, J.
Right arrow Articles by Das, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Das, J.
Right arrow Articles by Das, G.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation

Jyoti Das1,4, Guangwen Ren1, Liying Zhang1, Arthur I. Roberts1, Xin Zhao1, Alfred L.M. Bothwell2, Luc Van Kaer3, Yufang Shi1,5, and Gobardhan Das6

1 Department of Molecular Genetics, Microbiology, and Immunology, Robert Wood Johnson Medical School–University of Medicine and Dentistry of New Jersey, Piscataway, NJ 08854
2 Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520
3 Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232
4 Institute of Molecular Medicine, New Delhi 110020, India
5 Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
6 Immunology Group, International Center for Genetic Engineering and Biotechnology, New Delhi 110067, India

CORRESPONDENCE Yufang Shi: shiyufang2{at}gmail.com OR Gobardhan Das: dasgo{at}icgeb.res.in

Interleukin (IL)-17–producing T helper (Th17) cells play a critical role in the pathophysiology of several autoimmune disorders. The differentiation of Th17 cells requires the simultaneous presence of an unusual combination of cytokines: IL-6, a proinflammatory cytokine, and transforming growth factor (TGF) β, an antiinflammatory cytokine. However, the molecular mechanisms by which TGF-β exerts its effects on Th17 cell differentiation remain elusive. We report that TGF-β does not directly promote Th17 cell differentiation but instead acts indirectly by blocking expression of the transcription factors signal transducer and activator of transcription (STAT) 4 and GATA-3, thus preventing Th1 and Th2 cell differentiation. In contrast, TGF-β had no effect on the expression of retinoic acid receptor–related orphan nuclear receptor {gamma}t, a Th17-specific transcription factor. Interestingly, in Stat-6–/–T-bet–/– mice, which are unable to generate Th1 and Th2 cells, IL-6 alone was sufficient to induce robust differentiation of Th17 cells, whereas TGF-β had no effect, suggesting that TGF-β is dispensable for Th17 cell development. Consequently, BALB/c Stat-6–/–T-bet–/– mice, but not wild-type BALB/c mice, were highly susceptible to the development of experimental autoimmune encephalomyelitis, which could be blocked by anti–IL-17 antibodies but not by anti–TGF-β antibodies. Collectively, these data provide evidence that TGF-β is not directly required for the molecular orchestration of Th17 cell differentiation.


J. Das and G. Ren contributed equally to this paper.

Y. Shi and G. Das contributed equally to this paper.

Abbreviations used: EAE, experimental autoimmune encephalomyelitis; MBP, myelin basic protein; ROR, retinoic acid receptor–related orphan nuclear receptor; TGF-βRIIDN, dominant-negative TGF-βRII.

© 2009 Das et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Revising the Th17 recipe
Amy Maxmen
J. Exp. Med. 2009 206: 2304. [Full Text] [PDF]





  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS